The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
ARKE is an actively managed ETF aiming to provide a more tampered price return for shares of ARK Innovation ETF (ticker: ARKK), over a one-year period starting each July. The fund aims to cut the downside risk in half in exchange for a capped upside potential after a 5% performance hurdle is reached. ARKK holds US and foreign equities focused on disruptive innovation themes such as genomics, AI, robotics, and fintech. The fund holds shares of ARKK, sells at-the-money calls against the shares, buys at-the-money puts covering 50% of the fund's NAV, and buys out-of-the-money calls with any available premium in order to provide upside exposure above the 5% hurdle. All returns are before fees and expenses, which reduce overall fund returns. ARKE shareholders do not receive dividends, if any, from shares of ARKK. The strategy works best for investors willing to hold shares the entire outcome period. Outcomes will differ for those buying/selling mid-period.
The current price of ARKE is $20.08 USD — it has decreased by -2.52% in the past 24 hours. Watch ARK DIET Q3 Buffer stock price performance more closely on the chart.
What is ARK DIET Q3 Buffer stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on BATS exchange ARK DIET Q3 Buffer stocks are traded under the ticker ARKE.
In which sector is ARK DIET Q3 Buffer located?▼
ARK DIET Q3 Buffer operates in the Finance & Payments sector.
When did ARK DIET Q3 Buffer complete a stock split?▼
ARK DIET Q3 Buffer has not had any recent stock splits.
Where is ARK DIET Q3 Buffer headquartered?▼
ARK DIET Q3 Buffer is headquartered in St. Petersburg, United States.